Life Sciences in Piemonte

Login

Affiliate External Provider

bioPmed is the Italian innovation cluster dedicated to health care related product and services created in 2009 thanks to the intervention of Piemonte Region. bioPmed is financed in the framework of ERDF - POR Piemonte 2007-2013 Activity I.1.2 Poli di innovazione.

bioPmed is based on a community of around 470 companies, 3 universities and different research centers, foundations and associations active in Life Sciences fields. Since May 2009, 80 organizations have signed an agreement to create, build, support and animate the local cluster. Such organizations are the core organizations of bioPmed cluster.

The initiative is led by Bioindustry Park Silvano Fumero, the local science & technology park founded in 1998 which, since its creation, worked as system integrator for the development of Life Sciences in the Region.

In coherence with the European Union recommendations, bioPmed works to stimulate innovative activity by promoting intensive interactions, sharing of facilities and exchange of knowledge and expertise and by contributing effectively to technology transfer, networking and information dissemination among the undertakings in the cluster.

bioPmed is coherent with the guidelines contained in the "Europe 2020" strategy.

Bioindustry Park Silvano Fumero SpA, managing company of the bioPmed Healthcare Innovation Cluster, has been awarded the Gold Label for Cluster Management Excellence by the European Secretariat for Cluster Analysis.

For the 9th consecutive year, Universal Biotech, a consulting company specialized in the innovation management in the healthcare sector, launches its call for the Innovation Prize. This prize awards young start-ups (<8 years old) and academic research groups developing innovative projects in the field of human healthcare.

Since its launch, this competition has benefited or benefits from the support of numerous healthcare companies like GSK, L'Oréal, Pierre Fabre, Servier and many others, as well as internationally renowned academic institutions such as ANR, European Commission, Pasteur Institute and Karolinska Institutet which contributes to its achievement. The success of the Innovation Prize is demonstrated by the fact that among the 34 startups which have reached the final step of the competition, 60% of them raised fund or performed partnerships with an industrial.

For this 9th edition, the call for projects platform, Open Innovation Access, opens from February 1st till April 30th, 2017. Project leaders will be able to apply online by filling an application allowing jury members to evaluate the quality of projects according to the following criteria:• Scientific quality of the innovation,• Team quality,• Intellectual Property strategy,• Project feasibility,• Chances of success on the market.

After the selection step, Universal Biotech and the jury will reward the three winners at the Innovation Prize Awards Ceremony on October the 9th, 2017.

The Innovation Prize is an opportunity for you to introduce your innovative project to potential partners and investors. Furthermore, by participating in this competition, you will boost your visibility and also get a unique chance to obtain high-quality feedback from experts of the healthcare sector.